Clinipace and UNC-CH Partner to Launch NC Collaborative Stroke Registry

Article

Applied Clinical Trials

Registry managed by UNC through contract with North Carolina Department of Health and Human Services

Research Triangle Park, NC; May 17, 2005 -- Clinipace, Inc., a developer of software designed to support clinical research studies and registries, announced today that its web-based clinical research platform -- TempoTM -- has been implemented to support the North Carolina Collaborative Stroke Registry. Tempo, Clinipaces flagship product, is a web-based software solution that enables the collection and management of clinical research data, and manages project logistics on one unified technology platform.

Through a contract with the North Carolina Department of Health and Human Services (NCDHHS), the School of Public Health at the University of North Carolina at Chapel Hill (UNC-CH) manages the North Carolina Collaborative Stroke Registry, which is funded by the Centers for Disease Control (CDC).

Libby Puckett, Director of the NCDHHS's Heart Disease and Stroke Prevention Branch, remarks, "North Carolina's Acute Stroke Registry is unique in the degree of collaboration that has accompanied the work of applying for funding - first for the prototype phase, and in 2004 for implementation. Collaboration among the State Health Department, the UNC-Chapel Hill School of Public Health and NC hospitals of varying sizes and types helped our state to become one of only four in the country to be funded for this work." North Carolina is one of four states to receive funding for the registry from the Paul Coverdell National Acute Stroke Registry program.

The goal of the registry is to collect information on stroke patients from hospitals across the state, and use that information to improve treatment protocols and the management of stroke patients. Several hospitals across the state participated in the pilot program, and registry leaders aim to expand statewide hospital participation through the deployment of Clinipaces Tempo.

This project is particularly valuable for North Carolina citizens, as North Carolina is included in the region of the United States known as the "stroke belt" -- a group of states in the southeastern United States that have an unusually high rate of strokes. Unfortunately, the eastern areas of North Carolina, South Carolina, and Georgia are referred to as the "buckle" of the stroke belt due to their high stroke mortality rate -- twice that of the national average.

"This initiative is a critical step in the improvement of stroke management and prevention in North Carolina," said Wayne Rosamond, Principal Investigator and Professor of Epidemiology at the UNC School of Public Health. "With the active participation of North Carolina hospitals, we can not only learn more about a serious health problem here at home, but we can also be a model for other states as they face similar problems," added Rosamond. "Clinipace provides a solution that we believe will enable more hospitals to participate and will lead to improved quality of care."

"We are honored to be involved in this initiative to better understand the high incidence of stroke among North Carolinians," said Jeff Williams, CEO of Clinipace. "It is important work and a great example of how our web-based clinical research solution can facilitate collaborative clinical research between many geographically dispersed locations."

About Clinipace
Clinipace is a private software company providing solutions that support clinical research projects for pharmaceutical, biotechnology and medical device companies, as well as academic clinical research centers. Tempo, Clinipace's web-based flagship product, enables efficient collection and management of study data, while integrating critical workflows, including investigator training, monitoring and randomization within a single platform. Clinipace has received patents on several aspects of this platform including the integrated web-based randomization engine. For more information on Clinipace, please visit: www.clinipace.com

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.